Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 525-529, February 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chou, H-C.
Right arrow Articles by Kadlubar, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chou, H-C.
Right arrow Articles by Kadlubar, F. F.

Metabolic Activation of N-Hydroxy Arylamines and N-Hydroxy Heterocyclic Amines by Human Sulfotransferase(s)

H-C. Chou1, N. P. Lang and F. F. Kadlubar2

Office of Research (HFT-100), National Center for Toxicological Research, Jefferson, Arkansas 72079 [H-C. C., F. F. K.], and Departments of Pharmacology and Toxicology [H-C. C., F. F. K.] and Surgery [N. P. L.], University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

Several N-hydroxy metabolites of carcinogenic arylamines and heterocyclic amines were examined as substrates for bioactivation by human liver sulfotransferases (STs). Among the N-hydroxy derivatives studied, N-hydroxy-2-acetylaminofluorene, N-hydroxy-2-aminofluorene, N-hydroxy-4,4'-methylene-bis(2-chloroaniline), N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and N-hydroxy-2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole were each metabolically activated by 3'-phosphoadenosine-5'-phosphosulfate-dependent human liver STs. No ST-mediated DNA binding of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline or N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline was detected under our assay conditions. In the 12 human hepatic cytosols studied, the extent of 3'-phosphoadenosine-5'-phosphosulfate-dependent DNA binding of the N-hydroxy derivatives were all significantly correlated with levels of thermostable phenol ST (TS-PST) activity but not with thermolabile phenol ST or dehydroepiandrosterone ST activities. The propensity of these N-hydroxy arylamines and N-hydroxy heterocyclic amines to serve as selective substrates for human TS-PST was further confirmed by inhibition with 2,6-dichloro-4-nitrophenol and by thermostability studies.

N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and N-hydroxy-4,4'-methylene-bis(2-chloroaniline) were also used as substrates to study ST-dependent metabolic activation in other human tissue preparations. 3'-phosphoadenosine-5'-phosphosulfate-dependent DNA binding activity was detected in human liver and colon cytosols but not in pancreas, larynx, or urinary bladder epithelial cytosols. Since the TS-PST appears to be expressed polymorphically in human populations, the finding that human TS-PST is capable of metabolically activating N-hydroxy metabolites of several carcinogenic arylamines and heterocyclic amines suggests that TS-PST may have an important role in determining interindividual susceptibility to these environmental and dietary carcinogens.

1 Present address: National Institute of Preventive Medicine, Department of Health, 161 Kun-Yang Street, Nankang, Taipei, Taiwan, Republic of China.

2 To whom requests for reprints should be addressed.

Received 7/14/94. Accepted 11/30/94.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
Y.-T. Chung, L.-L. Hsieh, I-H. Chen, C.-T. Liao, S.-H. Liou, C.-W. Chi, Y.-F. Ueng, and T.-Y. Liu
Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese
Carcinogenesis, February 1, 2009; 30(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Tang, J. J. Liu, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, N. L. Nock, J. J. Yang, and B. A. Rybicki
Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Wu, E. Giovannucci, C. Byrne, E. A. Platz, C. Fuchs, W. C. Willett, and R. Sinha
Meat mutagens and risk of distal colon adenoma in a cohort of u.s. Men.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1120 - 1125.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Nagar, S. Walther, and R. L. Blanchard
Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein Degradation
Mol. Pharmacol., June 1, 2006; 69(6): 2084 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. U. Gamage, S. Tsvetanov, R. G. Duggleby, M. E. McManus, and J. L. Martin
The Structure of Human SULT1A1 Crystallized with Estradiol: AN INSIGHT INTO ACTIVE SITE PLASTICITY AND SUBSTRATE INHIBITION WITH MULTI-RING SUBSTRATES
J. Biol. Chem., December 16, 2005; 280(50): 41482 - 41486.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Nowell, B. Green, Y. M. Tang, R. Wiese, and F. F. Kadlubar
Examination of Human Tissue Cytosols for Expression of Sulfotransferase Isoform 1A2 (SULT1A2) Using a SULT1A2-Specific Antibody
Mol. Pharmacol., February 1, 2005; 67(2): 394 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Barnett, S. Tsvetanov, N. Gamage, J. L. Martin, R. G. Duggleby, and M. E. McManus
Active Site Mutations and Substrate Inhibition in Human Sulfotransferase 1A1 and 1A3
J. Biol. Chem., April 30, 2004; 279(18): 18799 - 18805.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Nowell, D. L. Ratnasinghe, C. B. Ambrosone, S. Williams, T. Teague-Ross, L. Trimble, G. Runnels, A. Carrol, B. Green, A. Stone, et al.
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African Americans and Caucasians: SUSAN NOWELL, D. LUKE RATNASINGHE, SUZANNE WILLIAMS, TERRI TEAGUE-ROSS, LINDSAY TRIMBLE, BRIDGETT GREEN, ANGIE STONE, GRAHAM GREENE, CHRISTINE B. AMBROSONE, NICHOLAS P. LANG, AND FRED F. KADLUBAR, National Center for Toxicological Research, Jefferson, Arkansas 72079; Central Arkansas Veteran's Healthcare System, Little Rock, Arkansas 72205 and University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
Toxicol Pathol, January 1, 2004; 32(1): 160 - 160.
[PDF]


Home page
CarcinogenesisHome page
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi
Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse
Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. M. Arlt, H. Glatt, E. Muckel, U. Pabel, B. L. Sorg, H. H. Schmeiser, and D. H. Phillips
Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase
Carcinogenesis, November 1, 2002; 23(11): 1937 - 1945.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima
Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids
Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander
Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts
Cancer Res., December 1, 2001; 61(24): 8689 - 8696.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. W. H. Coughtrie and L. E. Johnston
Interactions between Dietary Chemicals and Human Sulfotransferases{---}Molecular Mechanisms and Clinical Significance
Drug Metab. Dispos., April 1, 2001; 29(4): 522 - 528.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
N. J. Gooderham, S. Murray, A. M. Lynch, M. Yadollahi-Farsani, K. Zhao, A. R. Boobis, and D. S. Davies
Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans
Drug Metab. Dispos., April 1, 2001; 29(4): 529 - 534.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
A. J. Fretland, U. S. Devanaboyina, Y. Feng, M. A. Leff, G. H. Xiao, S. J. Webb, and D. W. Hein
Oral Administration of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Yields PhIP-DNA Adducts but Not Tumors in Male Syrian Hamsters Congenic at the N-acetyltransferase 2 (NAT2) Locus
Toxicol. Sci., February 1, 2001; 59(2): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. T. Frame, S. Ozawa, S. A. Nowell, H.-C. Chou, R. R. DeLongchamp, D. R. Doerge, N. P. Lang, and F. F. Kadlubar
A Simple Colorimetric Assay for Phenotyping the Major Human Thermostable Phenol Sulfotransferase (SULT1A1) Using Platelet Cytosols
Drug Metab. Dispos., September 1, 2000; 28(9): 1063 - 1068.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
R. S. King, C. H. Teitel, and F. F. Kadlubar
In vitro bioactivation of N-hydroxy-2-amino-{alpha}-carboline
Carcinogenesis, July 1, 2000; 21(7): 1347 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Wyss and R. Kaddurah-Daouk
Creatine and Creatinine Metabolism
Physiol Rev, July 1, 2000; 80(3): 1107 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Purewal, M. Velasco, A. J. Fretland, D. W. Hein, and M. J. Wargovich
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Induces a Higher Number of Aberrant Crypt Foci in Fischer 344 (Rapid) Than in Wistar Kyoto (Slow) Acetylator Inbred Rats
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 529 - 532.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
G. Paladino, B. Weibel, and C. Sengstag
Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains
Carcinogenesis, November 1, 1999; 20(11): 2143 - 2152.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. G. Stillwell, R. J. Turesky, R. Sinha, and S. R. Tannenbaum
N-Oxidative Metabolism of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in Humans Excretion of the N2-Glucuronide Conjugate of 2-Hydroxyamino-MeIQx in Urine
Cancer Res., October 1, 1999; 59(20): 5154 - 5159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Shibutani, A. Fernandes, N. Suzuki, L. Zhou, F. Johnson, and A. P. Grollman
Mutagenesis of the N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine DNA Adduct in Mammalian Cells. SEQUENCE CONTEXT EFFECTS
J. Biol. Chem., September 24, 1999; 274(39): 27433 - 27438.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Leff, P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan, and D. W. Hein
Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 182 - 187.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. H. Dingley, K. D. Curtis, S. Nowell, J. S. Felton, N. P. Lang, and K. W. Turteltaub
DNA and Protein Adduct Formation in the Colon and Blood of Humans after Exposure to a Dietary-relevant Dose of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 507 - 512.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
S. A. Nowell, J. S. Massengill, S. Williams, A. Radominska-Pandya, T. R. Tephly, Z. Cheng, C. P. Strassburg, R. H. Tukey, S. L. MacLeod, N. P. Lang, et al.
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved
Carcinogenesis, June 1, 1999; 20(6): 1107 - 1114.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Malfatti, K. S. Kulp, M. G. Knize, C. Davis, J. P. Massengill, S. Williams, S. Nowell, S. MacLeod, K. H. Dingley, K. W. Turteltaub, et al.
The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
Carcinogenesis, April 1, 1999; 20(4): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. A.J. Schut and E. G. Snyderwine
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Carcinogenesis, March 1, 1999; 20(3): 353 - 368.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R M Harris, R J Hawker, M J S Langman, S Singh, and R H Waring
Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis
Gut, February 1, 1998; 42(2): 272 - 275.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M. W. Coughtrie
Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
Human and Experimental Toxicology, July 1, 1996; 15(7): 547 - 555.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.